eugm 2011 | jemiai
TRANSCRIPT
ClicktoeditMaster/tlestyle
10/26/11
An early look at
Confirm Success with East® Clinical Trial Design Software System
on the Architect™ platform
6
1 Europe East UGM2011
• East today • Software vision • Example in hypertension • East® demo • Design questions
10/26/11
agenda
2 Europe East UGM2011
10/26/11 3 Europe East UGM2011
10/26/11
47oftheTop50biopharmaceu4calcompaniesuseCytelso:ware!+alldivisionsoftheFDA
an industry standard
4 Europe East UGM2011
10/26/11
what East has changed
5 Europe East UGM2011
10/26/11
Software vision
6 Europe East UGM2011
• Can I create designs in batches? • How should I choose the timing of the interim analysis? • How would I specify a first interim analysis strictly for futility
followed by a second interim analysis for both efficacy and futility?
• Can I customize the information I would like to use in a report?
• Can I specify my futility boundary in terms of conditional power or effect size?
• What are the true savings in sample size if you consider accrual patterns and overruns?
• Given observed data at an interim, can I compute the probability of success or simulate the rest of the trial?
10/26/11
Design questions
7 Europe East UGM2011
• Phase 3 clinical trial testing superiority of an angiotensin II receptor blocker vs. placebo
• Primary endpoint: change from baseline to week 6 in the 24-hour mean systolic blood pressure by ambulatory blood pressure monitoring
• Test the difference of two independent means using a 1-sided a = 0.025
• Would like the trial to have 90% power to detect an effect size of δ = -1.5 mm Hg when compared to placebo in a 1:1 allocation
• Can assume a common standard deviation of σ = 6 mm Hg • Accrual rate of 40 patients per month
10/26/11
Example in hypertension
8 Europe East UGM2011
East® Demo
10/26/11 9 Europe East UGM2011
• Ease of use • Reliability • Productivity • Communication • Advanced functionality using R • Breadth of designs available • Powerful simulation capabilities
10/26/11
benefits of East
10 Europe East UGM2011
ClicktoeditMaster/tlestyle
Peace of Mind with ACES® Controlled and Secured Trial Execution System
Business Confidential 26 October 2011 11
• Are interim decision rules pre-specified? • Are they carried out as pre-specified? • Who has access to them? • Who prepares the interim report? • Who has access to the interim report and how is
confidentiality maintained? • Can interim results be reverse engineered from
actions taken?
logistical and operational biases
10/26/11 Europe East UGM2011 12
10/26/11 13 Europe East UGM2011
no problem
“A well-trusted firewall established for trial conduct beyond those established for conventional group sequential trials can help provide assurance that statistical and operational biases have not been introduced.”
FDA Guidance on Adaptive Design (2010)
what is required?
10/26/11 Europe East UGM2011 14
• Web based technology to control flow of information and access to confidential documents
• Prevents operational bias by including the actual adaptive algorithm only in restricted appendix to Data Monitoring Committee (DMC) charter and tracking access to this document
• Establishes trustworthiness through secure password protected access to documents, execution of algorithms, and audit trail
ACES: Access Control Execution System
10/26/11 Europe East UGM2011 15
Create Documents (Protocol, SAP, DMC Charter)
Store/Archive Documents
Enroll Subjects &
Collect Responses
Send Response
Data to ISC
Perform Analysis and
Create Reports
Send Analysis to
DMC
Spo
nsor
IS
C
DM
C
Make Recommendati
on
Send Recommendation to Sponsor/
Steering Committee
Make Decision
about Trial
Ste
erin
g C
omm
ittee
After decision… 1. DMC notified 2. Drug Supply notified 3. IVRS notified
10/26/11 Europe East UGM2011
traditional process
16
• Inconsistency • Insecurity • Process Enforcement • Firewall Enforcement • Lack of Audit Trails
10/26/11 Europe East UGM2011 17
Concerns with Traditional Interim Analysis Processes
why do we need ACES?
10/26/11 Europe East UGM2011
Create Documents (Protocol, SAP, DMC Charter)
Store/Archive Documents
Enroll Subjects &
Collect Responses
Send Response
Data to ISC
Perform Analysis and
Create Reports
Send Analysis to
DMC
Spo
nsor
IS
C
DM
C
Make Recommendati
on
Send Recommendation to Sponsor/
Steering Committee
Make Decision
about Trial
Ste
erin
g C
omm
ittee
in ACES
in ACES
in ACES
After decision… 1. DMC notified 2. Drug Supply notified 3. IVRS notified
in ACES
ACES process
18
10/26/11 Europe East UGM2011 19
• Automate Analyses • Improve Efficiency • Reduce Bias • SAS Integration • R Integration (planned)
Workflow Automation
• Centralized Access • User Security • Audited Access • Categorization
Document Storage
• Protect Data and Information
• Maintain Blind • Protect Study Integrity • Reduce Bias
Secure Firewalls
• 21 CFR Part 11 Compliant
• System and Study Level Reporting
• All Access Recorded • Guarantees “Who Saw
What and When”
Auditing
• Make Better Decisions • Make Earlier Decisions • SAS Integration • R Integration (planned) • Customizable
Reporting
• Supports All Major Browsers
• SaaS Hosted Solution • 128-bit SSL Encryption
Global Access
how can ACES help?
Thank you Questions about East®? Call +1.617.661.2011 http://www.cytel.com/software/east.aspx
10/26/11
Q&A
20 Europe East UGM2011